Hydrogels for lentiviral gene delivery

Bibliography

• Flotte TR, Trapnell BC, Humphries M, Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing alpha1-antitrypsin: interim results. Hum Gene Ther 2011;22:1239-47
   PubMed Web of Science ®Google Scholar
• LeWitt PA, Rezai AR, Leehey MA, AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 2011;10:309-19
   PubMed Web of Science ®Google Scholar
• Nathwani AC, Tuddenham EG, Rangarajan S, Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 2011;365:2357-65
   PubMed Web of Science ®Google Scholar
• Bowles DE, McPhee SW, Li C, Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther 2012;20:443-55
   PubMed Web of Science ®Google Scholar
• Partridge KA, Oreffo ROC. Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies. Tissue Eng 2004;10:295-307
   PubMedGoogle Scholar
• Kofron MD, Laurencin CT. Bone tissue engineering by gene delivery. Adv Drug Deliv Rev 2006;58:555-76
   PubMed Web of Science ®Google Scholar
• DeLaporte L, Yang Y, Zelivyanskaya M, Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury. Mol Ther 2009;80:432-9
   Google Scholar
• DeLaporte L, Yan AL, Shea LD. Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials 2009;30:2361-8
   PubMed Web of Science ®Google Scholar
• DeLaporte L, Huang A, Ducommon MM, Patterned transgene expression in multiple channel bridges after spinal cord injury. Acta Biomater 2010;6:2889-97
   PubMed Web of Science ®Google Scholar
• Shin S, Tuinstra HM, Salvay DM, Shea LD. Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials 2010;31:4353-9
   PubMed Web of Science ®Google Scholar
• DeLaporte L, des Rieux LA, Zelivyanskaya ML, VEGF and FGF-2 delivery from spinal cord bridges to enhance angiogenesis following injury. J Biomed Mater Res A 2011;98:372-82
   PubMedGoogle Scholar
• Tuinstra H, Aviles MO, Shin S, Bridges delivering neurotrophin encoding lentivirus enhance regeneration following spinal cord injury. Biomaterials 2012;33:1618-26
   PubMed Web of Science ®Google Scholar
• Lipinski DM, Thake M, MacIaren RE. Clinical applications of retinal gene therapy. Prog Retin Eye Res 2012;32:22-47
   PubMed Web of Science ®Google Scholar
• Sakuma T, Barry MA, Ikeda Y. Lentiviral vectors: basic to translational. Biochem J 2012;443:603-18
   PubMed Web of Science ®Google Scholar
• Loser P, Huser A, Hillgenberg M, Advances in the development of non-human viral DNA-vectors for gene delivery. Curr Gene Ther 2002;2:161-71
   PubMedGoogle Scholar
• Jang JH, Houchin TL, Shea LD. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices 2004;1:127-38
   PubMed Web of Science ®Google Scholar
• Pannier AK, Shea LD. Controlled release systems for DNA delivery. Mol Ther 2004;10:19-26
   PubMed Web of Science ®Google Scholar
• McMahon J, Conroy S, Lyons M, Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev 2006;15:87-96
   PubMed Web of Science ®Google Scholar
• Jang JH, Schaffer DV, Shea LD. Engineering biomaterial systems to enhance viral vector gene delivery. Mol Ther 2011;19:1407-15
   PubMed Web of Science ®Google Scholar
• Dull T, Zufferey R, Kelly M, A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72:8463-71
   PubMed Web of Science ®Google Scholar
• Kaplitt MG, Feigin A, Tang C, Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 2007;369:2097-105
   PubMed Web of Science ®Google Scholar
• Kay MA, Manno CS, Ragni MV, Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000;24:257-61
   PubMed Web of Science ®Google Scholar
• Mah C, Fraites TJ, Zolotukhin I, Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. Mol Ther 2002;6:106-12
   PubMed Web of Science ®Google Scholar
• Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009;326:818-23
   PubMed Web of Science ®Google Scholar
• Maguire AM, High KA, Auricchio A, Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet 2009;374:1597-605
   PubMed Web of Science ®Google Scholar
• Maguire AM, Simonelli F, Pierce EA, Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008;358:2240-8
   PubMed Web of Science ®Google Scholar
• Gower RM, Shea LD. Biomaterial scaffolds for controlled, localized gene delivery of regenerative factors. Adv Wound Care 2012: published online 26 January 2012, doi:10.1089/wound2011.0325
   Google Scholar
• Yi Y, Noh MJ, Lee KH. Current advances in retroviral gene therapy. Curr Gene Ther 2011;11:218-28
   PubMed Web of Science ®Google Scholar
• Cabrera-Salazar MA, Roskelley EM, Bu J, Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease. Mol Ther 2007;15:1782-8
   PubMed Web of Science ®Google Scholar
• Coffin J, Hughes S, Varmus H. Retroviruses. Cold Spring Harbor Laboratory Press, NY; 1997
   Google Scholar
• Zhang X, Godbey W. Viral vectors for gene delivery in tissue engineering. Adv Drug Deliv Rev 2006;58:515-34
   PubMed Web of Science ®Google Scholar
• Humbert JM, Frecha C, Amirache Bouafia F, Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells. J Virol 2012;86:5192-203
   PubMed Web of Science ®Google Scholar
• Kootstra NA, Verma IM. Gene therapy with viral vectors. Ann Rev Pharm Toxicol 2003;43:413-39
   PubMed Web of Science ®Google Scholar
• Aviles MO, Shea LD. Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds. Drug Deliv Transl Res 2011;1:91-101
   Google Scholar
• Raut SD, Lei P, Padmashali RM, Andreadis ST. Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays. J Control Release 2010;144:213-20
   PubMed Web of Science ®Google Scholar
• Shepard JA, Huang A, Shikanov A, Shea LD. Balancing cell migration with matrix degradation enhances gene delivery to cells cultured three-dimensionally within hydrogels. J Control Release 2010;146:128-35
   PubMed Web of Science ®Google Scholar
• Shin S, Shea LD. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol Ther 2010;18:700-6
   PubMed Web of Science ®Google Scholar
• Shepard JA, Wesson PJ, Wang CE, Gene therapy vectors with enhanced transfection based on hydrogels modified with affinity peptides. Biomaterials 2011;32:5092-9
   PubMed Web of Science ®Google Scholar
• Kidd ME, Shin S, Shea LD. Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo. J Control Release 2012;157:80-5
   PubMed Web of Science ®Google Scholar
• Shepard JA, Virani FR, Goodman AG, Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis. Biomaterials 2012;33:7412-21
   PubMed Web of Science ®Google Scholar
• Baier Leach J, Bivens KA, Patrick CW Jr, Schmidt CE. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 2003;82:578-89
   PubMed Web of Science ®Google Scholar
• Storm C, Pastore JJ, MacKintosh FC, Nonlinear elasticity in biological gels. Nature 2005;435:191-4
   PubMed Web of Science ®Google Scholar
• Raeber G, Lutolf M, Hubbell J. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 2005;89:1374-88
   PubMed Web of Science ®Google Scholar
• Cho NJ, Elazar M, Xiong A, Viral infection of human progenitor and liver-derived cells encapsulated in three-dimensional PEG-based hydrogel. Biomed Mater 2008;4:011001-8
   Google Scholar
• Padmashali RM, Andreadis ST. Engineering fibrinogen-binding VSV-G envelope for spatially-and cell-controlled lentivirus delivery through fibrin hydrogels. Biomaterials 2011;32:3330-9
   PubMed Web of Science ®Google Scholar
• McMahon SS, Nikolskaya N, Choileáin SN, Thermosensitive hydrogel for prolonged delivery of lentiviral vector expressing neurotrophin-3 in vitro. J Gene Med 2011;13:591-601
   PubMed Web of Science ®Google Scholar
• Neumann AJ, Schroeder J, Alini M, Enhanced adenovirus transduction of hMSCs using 3D hydrogel cell carriers. Mol Biotechnol 2012;53(2):207-16
   Web of Science ®Google Scholar
• Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005;109:256-74
   PubMed Web of Science ®Google Scholar
• Kasper FK, Kushibiki T, Kimura Y, In vivo release of plasmid DNA from composites of oligo (poly (ethylene glycol) fumarate) and cationized gelatin microspheres. J Control Release 2005;107:547-61
   PubMed Web of Science ®Google Scholar
• Segura T, Anderson BC, Chung PH, Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials 2005;26:359-71
   PubMed Web of Science ®Google Scholar
• Zhang LH, Luo T, Zhang C, Anti DNA antibody modified coronary stent for plasmid gene delivery: results obtained from a porcine coronary stent model. J Gene Med 2011;13:37-45
   PubMed Web of Science ®Google Scholar
• Lee HH, Haleem AM, Yao V, Release of bioactive adeno-associated virus from fibrin scaffolds: effects of fibrin glue concentrations. Tissue Eng Part A 2011;17:1969-78
   PubMed Web of Science ®Google Scholar
• Behravesh E, Jo S, Zygourakis K, Mikos AG. Synthesis of in situ cross-linkable macroporous biodegradable poly(propylene fumarate-co-ethylene glycol) hydrogels. Biomacromolecules 2002;3:374-81
   PubMed Web of Science ®Google Scholar
• Ford MC, Bertram JP, Hynes SR, A macroporous hydrogel for the coculture of neural progenitor and endothelial cells to form functional vascular networks in vivo. Proc Natl Acad Sci USA 2006;103:2512-17
   PubMed Web of Science ®Google Scholar
• Keskar V, Marion NW, Mao JJ, Gemeinhart RA. In vitro evaluation of macroporous hydrogels to facilitate stem cell infiltration, growth, and mineralization. Tissue Eng Part A 2010;15:1695-707
   Web of Science ®Google Scholar
• Hwang Y, Sangaj N, Varghese S. Interconnected macroporous poly(ethylene glycol) cyrogels as a cell scaffold for cartilage tissue engineering. Tissue Eng Part A 2010;16:3033-41
   PubMed Web of Science ®Google Scholar
• Scott EA, Nichols MD, Kuntz-Willits R, Elbert DL. Modular scaffolds assembled around living cells using poly(ethylene glycol) microspheres with macroporation via a non-cytotoxic porogen. Acta Biomater 2010;6:29-38
   PubMed Web of Science ®Google Scholar
• Jang JH, Shea LD. Controllable delivery of non-viral DNA from porous scaffolds. J Control Release 2003;86:157-68
   PubMed Web of Science ®Google Scholar
• Sailaja G, HogenEsch H, North A, Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response. Gene Ther 2002;9:1722-9
   PubMed Web of Science ®Google Scholar
• Mok H, Park JW, Park TG. Microencapsulation of PEGylated adenovirus within PLGA microspheres for enhanced stability and gene transfection efficiency. Pharm Res 2007;24:2263-9
   PubMed Web of Science ®Google Scholar
• Gary DJ, Lee H, Sharma R, Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes. ACS Nano 2011;5:3493-505
   PubMed Web of Science ®Google Scholar
• Vandendriessche T, Thorrez L, Acosta-Sanchez A, Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. J Thromb Haemost 2007;5:16-24
   PubMed Web of Science ®Google Scholar
• Brown BD, Sitia G, Annoni A, In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 2007;109:2797-805
   PubMed Web of Science ®Google Scholar
• DePolo NJ, Reed JD, Sheridan PL, VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2000;2:218-22
   PubMed Web of Science ®Google Scholar
• Croyle MA, Callahan SM, Auricchio A, PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. J Virol 2004;78:912-21
   PubMed Web of Science ®Google Scholar
• Lin CC, Boyer PD, Aimetti AA, Anseth KS. Regulating MCP-1 diffusion in affinity hydrogels for enhancing immuno-isolation. J Control Release 2010;142:384-91
   PubMed Web of Science ®Google Scholar
• Su J, Hu B-H, Lowe WL Jr, Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials 2010;31:308-14
   PubMed Web of Science ®Google Scholar
• Cheung CY, Anseth KS. Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets. Bioconjug Chem 2006;17:1036-42
   PubMed Web of Science ®Google Scholar
• De Laporte L, Shea LD. Matrices and scaffolds for DNA delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:292-307
   PubMed Web of Science ®Google Scholar
• Lei P, Padmashali RM, Andreadis ST. Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels. Biomaterials 2009;30:3790-9
   PubMed Web of Science ®Google Scholar